Argentina Fertility Services Market Overview,2030

The market for fertility services in Argentina experienced significant growth after the introduction of Law 26.862 in 2013, also known as the Assisted Reproduction Law. This pivotal law required both public and private health insurers to provide coverage for assisted reproductive technologies (ART), greatly enhancing accessibility for various socioeconomic groups. The primary aim of the legislation was to foster equitable ART access, acknowledging infertility as a health issue and reproductive support as a fundamental right rather than a luxury. Consequently, Argentina emerged as one of the leading nations in Latin America for fertility assistance, extending services to single people, same-sex partnerships, and those of older maternal age. In Argentina, the first successful IVF procedure took place in 1986, yet broad accessibility did not materialize until the 1990s and early 2000s, when numerous private clinics opened in major cities such as Buenos Aires, Córdoba, and Rosario. The 2013 legislation spurred a swift expansion of IVF clinics throughout the country, incorporating public sector offerings and making ART services more available and affordable. Currently, notable clinics like CEGYR, Procrearte, and IFER provide a wide array of treatments such as IVF, ICSI, IUI, gamete donation, and embryo analysis. Assisted Reproductive Technology (ART) encompasses medical techniques that involve managing eggs, sperm, or embryos outside the body to accomplish conception. This category includes procedures like in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), gamete donation, and embryo storage. Argentina is increasingly directing its research and development towards embryo freezing, with clinics adopting vitrification methods and artificial intelligence-based grading systems to boost success rates. Cryobanking has become a common service, aiding in fertility preservation for individuals undergoing cancer treatment, those choosing to delay parenthood, and programs for donating embryos.

According to the research report, ""Argentina Fertility Service Market Overview, 2030,"" published by Bonafide Research, the Argentina Fertility Service market is expected to reach a market size of USD 530 Million by 2030. This expansion is supported by inclusive laws, increasing infertility rates, and improved clinical facilities. The area underwent significant change following the introduction of Law 26,862 in 2013, which ensures all adults can access assisted reproductive technologies (ART) without regard to their marital status, sexual orientation, or gender identity. This legislation requires both public and private health insurance to cover these services, making Argentina one of the most advanced providers of fertility care in Latin America. In recent times, there has been significant expansion in partnerships between public and private clinics. Fertility centers are increasingly becoming a part of hospital systems, and private clinics are moving into areas that lack services. Notable clinics like Halitus Instituto Médico and Cegyr stand out in the market, providing advanced ART options such as IVF, ICSI, the use of donor gametes, and embryo freezing. Halitus is recognized for its embryo grading through AI and its access to an international gamete donation bank, whereas Cegyr, which is part of the Eugin Group, incorporates genetic testing and boasts one of the largest gamete banks in Argentina. Support from the government is a vital factor driving opportunities. Initiatives funded by the public sector and subsidies from provinces are enhancing access to ART outside of Buenos Aires, while national registries and monitoring systems ensure adherence to ethical and medical practices. The Ministry of Health keeps a record of licensed facilities, and ART procedures are required to fulfill strict quality standards as per Law 26,862.

Argentina's fertility service by procedure is divided into IVF with ICSI, IUI, IVF without ICSI, Surrogacy and Others reproductive health scene has changed remarkably since the implementation of Law 26,862 in 2013, which ensured equal access to assisted reproductive technologies (ART) in both public and private sectors. A major change has been the increasing use of IVF combined with intracytoplasmic sperm injection (ICSI), which has now become the leading method in advanced clinics like CEGYR, Halitus, and WeFIV. ICSI is especially preferred for issues related to male infertility and accurate fertilization, with costs between USD 3,000 and 4,500 per cycle. Its widespread use showcases both its effectiveness in clinical settings and the heightened interest in sophisticated reproductive choices among various family types. Intrauterine insemination (IUI) continues to be a favored and economical initial treatment choice, especially for single women and same-sex partners. With lower costs and minimal invasiveness, IUI is readily accessible and legally endorsed under Argentina’s inclusive ART laws. Nevertheless, its success rates are inferior to IVF, making it more appropriate for cases of mild infertility or when using donor sperm. IVF without ICSI is selectively available, generally for younger couples with ideal sperm conditions and no previous fertilization issues. While it can be performed, its application is restricted due to the higher success rates and wider range of conditions where ICSI is beneficial. Surrogacy in Argentina involves legal challenges. Although not directly forbidden, it lacks regulation, resulting in unpredictable judicial outcomes. Recent decisions by the Supreme Court have confirmed that the birth mother retains legal rights, even in altruistic cases, generating uncertainty for parents-to-be especially male couples in same-sex partnerships. Efforts for legislative change are in progress, but a cohesive national policy is still absent.

In Argentina fertility service by cause of infertility is divided into Male Infertility and Female Infertility, infertility in women is the primary reason for reproductive issues, making up the bulk of consultations and treatments in assisted reproductive technology (ART). This problem is often connected to factors related to age, as more women are choosing to postpone having children until their late 30s and early 40s due to their careers, education, or personal decisions. This shift has resulted in a higher occurrence of reduced ovarian reserve, lower egg quality, and an increased risk of miscarriages. Furthermore, health issues like polycystic ovary syndrome (PCOS), endometriosis, and blocked fallopian tubes are commonly diagnosed. In vitro fertilization (IVF) continues to be the most common treatment, while artificial insemination is the segment experiencing the fastest growth, indicating improved access and affordability. On the other hand, male infertility, which has often been overlooked, is increasingly becoming recognized and now accounts for almost half of all infertility cases. Factors like being overweight, smoking, drinking alcohol, and contact with environmental pollutants are being identified more frequently as reasons for declining sperm quality and hormonal issues. Improvements in diagnostics such as testing for DNA fragmentation, assessing oxidative stress, and using computer-assisted analysis of semen are enhancing the accuracy of identifying and treating infertility. Clinics are also expanding their services for intracytoplasmic sperm injection (ICSI) and donor sperm to tackle cases of severe male infertility. These developments highlight the necessity for comprehensive fertility services in Argentina, where both male and female infertility are influenced by biological, societal, and environmental factors. Ongoing investments in diagnostics, public awareness, and equitable access to ART under Law 26,862 will play a vital role in promoting reproductive health for all genders and future generations.

Argentina’s fertility service by end user is divided into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes is primarily influenced by a leading network of private medical facilities that excel in service provision, innovation, and the number of patients treated. Notable clinics like Halitus Instituto Médico, CEGYR, and WeFIV provide extensive ART services, which encompass IVF, ICSI, donor programs, and freezing of embryos. These centers are furnished with high-tech embryology laboratories, AI-assisted assessment systems, and access to international donors, establishing them as the foremost providers of assisted reproductive technologies across the country. Their significant role is further supported by Argentina’s Comprehensive ART Law 26,862, which requires both public and private health insurers to cover fertility treatments, thus enhancing accessibility for various social groups. Public hospitals operate within the same regulatory context but have a narrower role in delivering ART. Institutions like Hospital Italiano and Hospital de Clínicas provide subsidized IVF and fertility testing, yet limitations in capacity and regional differences often lead patients to seek services at private clinics. These hospitals are more inclined to handle intricate cases, fertility preservation related to cancer treatments, and comprehensive reproductive healthcare, particularly in metropolitan areas. Surgical facilities, usually part of hospitals or fertility practices, tackle infertility issues such as endometriosis, fibroids, and blocked fallopian tubes. These procedures are commonly carried out through laparoscopic or hysteroscopic methods and are vital for enhancing natural fertility or optimizing ART results. Nevertheless, accessibility to specialized surgical services is inconsistent, with a concentration in Buenos Aires and a few provincial capitals. Research institutions are rapidly growing, with clinical centers and university-associated laboratories investing in embryo freezing, gamete conservation, and AI-enhanced diagnostic tools. Argentina’s fertility research and development is increasingly aimed at enhancing vitrification techniques, non-invasive embryo viability assessments, and genetic testing.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Fertility Services Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Procedure
• IVF with ICSI
• IUI
• IVF without ICSI
• Surrogacy
• Others

By Service
• Fresh Non-Donor
• Frozen Non-Donor
• Egg and Embryo Banking
• Fresh Donor
• Frozen Donor
By Cause of Infertility
• Male Infertility
• Female Infertility

By End User
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes
Show more